ישראל - עברית - Ministry of Health

merck serono ltd - cetrorelix as acetate - אבקה וממס להכנת תמיסה להזרקה - cetrorelix as acetate 0.25 mg/vial - cetrorelix - cetrorelix - prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.

ישראל - עברית - Ministry of Health

merck serono ltd - levothyroxine sodium - טבליה - levothyroxine sodium 50 mcg - levothyroxine sodium - levothyroxine sodium - euthyrox 25 - 200 microgram :- treatment of benign euthyroid goitre.- prophylaxis of relapse after surgery for euthyroid goitre, depending on the post - operative hormone status.- substitution therapy in hypothyroidism.- suppression therapy in thyroid cancer.euthyrox 25 - 100 microgram :- concomitant supplementation during anti-thyroid drug treatment of hyperthyroidism.euthyrox 100/150/200 microgram :- diagnostic use for thyroid suppression testing.

ישראל - עברית - Ministry of Health

merck serono ltd - levothyroxine sodium - טבליה - levothyroxine sodium 100 mcg - levothyroxine sodium - levothyroxine sodium - euthyrox 25 - 200 microgram :- treatment of benign euthyroid goitre.- prophylaxis of relapse after surgery for euthyroid goitre, depending on the post - operative hormone status.- substitution therapy in hypothyroidism.- suppression therapy in thyroid cancer.euthyrox 25 - 100 microgram :- concomitant supplementation during anti-thyroid drug treatment of hyperthyroidism.euthyrox 100/150/200 microgram :- diagnostic use for thyroid suppression testing.

ישראל - עברית - Ministry of Health

merck serono ltd - cetuximab - תמיסה לאינפוזיה - cetuximab 5 mg/ml - cetuximab - cetuximab - erbitux® is indicated for the treatment of patients with epidermal growth factor receptor (egfr) - expressing, kras wild-type metastatic colorectal cancer• in combination with irinotecan-based chemotherapy• in first-line in combination with folfox• as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecanerbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck (scchn)• in combination with radiation therapy for locally advanced disease• in combination with platinum-based chemotherapy for recurrent and/or metastatic disease• as a single agent after failure of platinum-based chemotherapy for recurrent and/or metastatic disease

ישראל - עברית - Ministry of Health

merck serono ltd - interferon beta 1a - תמיסה להזרקה - interferon beta 1a 44 mcg/ml - interferon beta-1a - interferon beta-1a - rebif (interferone beta-1a) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of physical disability. efficacy of rebif in chronic progressive multiple sclerosis has not been established.

ישראל - עברית - Ministry of Health

merck serono ltd. - כלל האוכלוסיה - מחטים למכשיר הזרקה אלקטרוני לתכשיר רביף לטיפול בטרשת נפוצה

ישראל - עברית - Ministry of Health

merck serono ltd - cladribine - טבליה - cladribine 10 mg - cladribine

ישראל - עברית - Ministry of Health

merck serono ltd - follitropin alfa; lutropin alfa - תמיסה להזרקה - lutropin alfa 150 iu / 0.48 ml; follitropin alfa 300 iu / 0.48 ml - follitropin alfa

ישראל - עברית - Ministry of Health

merck serono ltd - cetrorelix as acetate - אבקה וממס להכנת תמיסה להזרקה - cetrorelix as acetate 0.25 mg/vial - cetrorelix

ישראל - עברית - Ministry of Health

merck serono ltd - cetrorelix as acetate - אבקה וממס להכנת תמיסה להזרקה - cetrorelix as acetate 0.25 mg/vial - cetrorelix